Intravenous Immunoglobulin (IVIg) for unexplained infertility: a case series

被引：0

作者：

Genest, G. ^{[1
]}

Elliott, B. ^{[2
]}

Spitzer, K. ^{[3
]}

Laskin, C. A. ^{[4
]}

Buckett, W. ^{[5
]}

Lapensee, L. ^{[6
,7
]}

Kadoch, I. J. ^{[6
,7
]}

Gold, P. ^{[1
]}

机构：

[1] McGill Univ, Montreal Gen Hosp, Dept Immunol, Montreal, PQ, Canada

[2] McGill Univ, Montreal, PQ, Canada

[3] Trio Fertil, Toronto, ON, Canada

[4] Univ Toronto, Dept Med & Obstet, Toronto, ON, Canada

[5] McGill Univ, Reprod Ctr, Montreal, PQ, Canada

[6] Univ Montreal, Dept Obstet & Gynecol, Montreal, PQ, Canada

[7] Ovo Clin, Dept Reprod Med, Montreal, PQ, Canada

来源：

CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY | 2018年 / 45卷 / 05期

关键词：

Immunology; Infertility; Maternal-fetal medicine; PREGNANCY;

D O I：

10.12891/ceog4566.2018

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

Intravenous Immunoglobulin (IVIg) is a potential treatment for immune mediated reproductive failure (IMRF), but its role in infertility treatments remains controversial. There is evidence that administering IVIg before conception improves pregnancy outcomes. In the present cohort, 13/15 (86%) patients had a live birth after receiving pre-conceptual Wig at immunomodulatory doses. No serious maternal or fetal side effects directly attributable to IVIg were reported. The present results support the need for a randomized controlled trial (RCT) with this protocol.

引用

页码：699 / 701

页数：3

共 50 条

[1] Intravenous Immunoglobulin for Repeated IVF Failure and Unexplained Infertility
Virro, Michael R.
Winger, Edward E.
Reed, Jane L.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY, 2012, 68 (03) : 218 - 225
[2] Intravenous immunoglobulin (IVIG)
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2006, 48 (1249): : 101 - 103
[3] Scleromyxedema - A case series highlighting long-term outcomes of treatment with intravenous immunoglobulin (IVIG)
Blum, Marissa
Wigley, Fredrick M.
Hummers, Laura K.
MEDICINE, 2008, 87 (01) : 10 - 20
[4] Recovery of severely ill COVID-19 patients by intravenous immunoglobulin (IVIG) treatment: A case series
Mohtadi, Negar
Ghaysouri, Abas
Shirazi, Samira
Ansari, Sara
Shafiee, Elham
Bastani, Elham
Kokhazadeh, Taleb
Tavan, Hamed
VIROLOGY, 2020, 548 : 1 - 5
[5] Intravenous Immunoglobulin (IVIG) for Chronic Norovirus
Chung, Yae-Eun
Spiller, Robert
Young, Patrick
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2985 - S2985
[6] Use of intravenous immunoglobulin G (IVIG)
Looney, RJ
Huggins, J
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2006, 19 (01) : 3 - 25
[7] PHARMACOKINETICS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN INFANTS
WEISMAN, LE
RODRIQUEZ, WJ
KIM, HW
BARON, PA
FISCHER, GW
PECK, CC
HEMMING, VG
PEDIATRIC RESEARCH, 1986, 20 (04) : A210 - A210
[8] A protocol for the desensitization to intravenous immunoglobulin (IVIg)
Salomon, M.
Hostoffer, R., Jr.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2007, 119 (01) : S180 - S180
[9] PHARMACOKINETICS OF INTRAVENOUS IMMUNOGLOBULIN (IVIG) IN NEONATES
WEISMAN, LE
FISCHER, GW
HEMMING, VG
PECK, CC
PEDIATRIC RESEARCH, 1986, 20 (04) : A394 - A394
[10] INTRAVENOUS IMMUNOGLOBULIN (IVIG) HITS HIT
Sanchez, Oriana
San Luis, Christa
Smalley, Zachary
Farag, Nujud
Sharma, Sameer
CRITICAL CARE MEDICINE, 2021, 49 (01) : 297 - 297

← 1 2 3 4 5 →